A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer
2025; Nature Portfolio; Volume: 11; Issue: 1 Linguagem: Inglês
10.1038/s41523-025-00720-3
ISSN2374-4677
AutoresRita A. Mukhtar, Soumya Gottipati, Christina Yau, Sara López‐Tarruella, Helena Earl, Larry Hayward, Louise Hiller, Marie Osdoit, Marieke van der Noordaa, Diane De Croze, Anne-Sophie Hamy, Marick Laé, Fabien Reyal, Gabe S. Sonke, Tessa G. Steenbruggen, Maartje van Seijen, Jelle Wesseling, Miguel Martín, Marı́a del Monte-Millán, Judy C. Boughey, Matthew P. Goetz, Tanya L. Hoskin, Vicente Valero, Stephen B. Edge, Jean Abraham, Thomas John, Carlos Caldas, Janet Dunn, Elena Provenzano, Stephen‐John Sammut, Jeremy Thomas, A Graham, Peter Hall, Lorna Mackintosh, Fang Fan, Andrew K. Godwin, Kelsey Schwensen, Priyanka Sharma, Angela DeMichele, Kimberly Cole, Lajos Pusztai, Mi‐Ok Kim, Laura van ′t Veer, David Cameron, Laura J. Esserman, W. Fraser Symmans,
Tópico(s)HER2/EGFR in Cancer Research
Referência(s)